FDA cleared the Safe AQ Easy Blood Glucose Monitoring System; Safe AQ Care Blood Glucose Monitoring System from Changsha Sinocare, Inc. on Oct 30, 2026 under K260738, a special 510(k). The device falls under product code NBW, System, Test, Blood Glucose, Over The Counter, regulated at 21 CFR 862.1345 as a Class 2 device. The review panel was Clinical Chemistry.
FDA logged the submission as received on Mar 6, 2026. The decision came 238 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Changsha Sinocare, Inc. in the last 12 months of the tracker.